Eragny-sur-Oise, France, September 11, 2019 – SAFE ORTHOPAEDICS (FR0012452746 – SAFOR), a company specialising in the design and marketing of implants and single-use instruments for spinal surgery, announces the publication in the European Journal of Orthopaedic Surgery & Traumatology of an article written by a team from the Kremlin-Bicêtre University Hospital presenting a one-year randomised study on 40 patients who underwent spinal surgery. The objective was to compare the cost of reusable and single-use instruments.
“Our study shows that single-use instruments have a place in spinal surgery, not only because of the cost savings they provide for hospitals, but also because of their ease of use for surgeons and the comfort they provide for hospital staff. Once this innovative technology has been apprehended, the instruments are reliable and versatile. Without modifying surgical technique, they make it possible to optimize the operating durations as measured in the study,” explained Professor Charles Court, surgeon at the Kremlin-Bicêtre University Hospital.
“We thank and congratulate the Kremlin Bicêtre University Hospital team for publishing its study on our technologies in the European Journal of Orthopaedic Surgery & Traumatology, the leading scientific journal in our sector. This randomized study shows an 80% reduction in pre- and post-operative duration using our technologies and offers the benefit to surgeons of having a sterile, ready-to-use technology. Helping the surgeon reduce surgical risks for the patient and enabling hospitals to reduce their costs are important issues for Safe Orthopaedics,” declared Pierre Dumouchel, CEO of Safe Orthopaedics.
About Safe Orthopaedics
Founded in 2010, Safe Orthopaedics, is a French medical technology company that offers the safest technologies to treat spinal fractures. Delivered sterile, all implants and respective disposable instrumentation are available to the surgeon at any time, anywhere. These technologies enable minimally invasive approaches, redcucing risks of cross contamination and infection in the interest of the patient. Protected by 17 patent families, SteriSpineTM kits are CE marked and FDA cleared. The company is based in Eragny-sur-Oise (95) and has 40 employees.
For more information: www.SafeOrthopaedics.com